A phase 2 trial finds that for patients with HER2+ metastatic colorectal cancer, dual HER2-inhibitor therapy can be a similarly efficacious but less toxic alternative to EGFR inhibitor therapy.

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research and the like.

Meetings designed to distribute grant money to fund research were canceled as part of a communications freeze at health ...

I’m a health researcher. NIH’s pause on research grants could have a devastating cost. This is a potentially devastating ...

Cancellations of NIH grant review panels, in particular, could affect cancer research grants and funding. In these NIH grant ...

An email obtained by NPR says NIH employees are subject to a travel freeze and offers of employment are being rescinded.

A temporary freeze on meetings on the National Institutes of Health could lead to delays in disbursing research grants and in approving crucial clinical trials.

MANHASSET, N.Y.--(BUSINESS WIRE)--The Feinstein Institutes for Medical Research has been awarded a five-year, $2.9 million grant from the National Institutes of Health (NIH) to investigate the ...

National Institutes of Health (NIH) Director Monica Bertagnolli will resign on Jan. 17, she told staff this week, ending her tenure as the head of the $48 billion biomedical research agency after ...

Co-authors reported relationships with the NIH, the National Cancer Institute, the Children's Cancer Research Fund, St Jude's Children's Research Hospital, Servier, Amgen, Incyte, Jazz ...